Evidence map›Paper›PMID 42618732›Full record

ArticleBone marrow transplantation2026

Prognostic factors of second allogeneic hematopoietic stem cell transplantation for relapsed or refractory myelodysplastic syndromes: nationwide registry analysis.

Kamma Shiraishi, Yoshimitsu Shimomura, Hiroki Hosoi, Kyoko Fuse, Machiko Fujioka, Shinsuke Kusakabe, Satoshi Yoshihara, Ken Takase, Toshihiro Matsukawa, Toru Izumi and 13 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Kamma ShiraishiDepartment of Hematology and Oncology, The University of Osaka Hospital, Osaka, Japan. shk.kamma@gmail.com.ORCID http://orcid.org/0009-0004-1980-3847
Yoshimitsu ShimomuraDepartment of Hematology, Kobe City Medical Center General Hospital, Hyogo, Japan.ORCID http://orcid.org/0000-0003-1018-9508
Hiroki HosoiDepartment of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan.ORCID http://orcid.org/0000-0002-8682-7476
Kyoko FuseFaculty of Medicine, Department of Hematology, Endocrinology and Metabolism, Niigata University, Niigata, Japan.
Machiko FujiokaDepartment of Hematology, Sasebo City General Hospital, Nagasaki, Japan.ORCID http://orcid.org/0000-0002-1661-8273
Shinsuke KusakabeDepartment of Hematology and Oncology, The University of Osaka Hospital, Osaka, Japan.ORCID http://orcid.org/0000-0002-9814-7611
Satoshi YoshiharaDepartment of Hematology, Hyogo Medical University Hospital, Hyogo, Japan.ORCID http://orcid.org/0000-0002-8537-2422
Ken TakaseDepartment of Hematology, NHO Kyushu Medical Center, Fukuoka, Japan.
Toshihiro MatsukawaDepartment of Hematology, Hokkaido University Hospital, Hokkaido, Japan.
Toru IzumiDepartment of Hematology, National Hospital Organization Sendai Medical Center, Miyagi, Japan.
Keisuke KataokaDivision of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.ORCID http://orcid.org/0009-0006-7339-9800
Naoyuki UchidaDepartment of Hematology, Federation of National Public Service Personnel Mutual Aid Associations, Toranomon Hospital, Tokyo, Japan.ORCID http://orcid.org/0000-0001-5952-5926
Nobuhiro KanemuraDepartment of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan.ORCID http://orcid.org/0000-0001-8449-9918
Senji KasaharaDepartment of Hematology, Gifu Municipal Hospital, Gifu, Japan.
Hiroatsu IidaDepartment of Cell Therapy/Hematology, National Hospital Organization Nagoya Medical Center, Aichi, Japan.
Jun IshikawaDepartment of Hematology, Osaka International Cancer Institute, Osaka, Japan.
Hirohisa NakamaeDepartment of Hematology, Osaka Metropolitan University Hospital, Osaka, Japan.ORCID http://orcid.org/0000-0003-4203-990X
Kazunori ImadaDepartment of Hematology, Japanese Red Cross Osaka Hospital, Osaka, Japan.ORCID http://orcid.org/0000-0002-0945-0513
Koji KawamuraDivision of Hematology and Clinical Laboratory Medicine, Department of Multidisciplinary Internal Medicine, Tottori University, Tottori, Japan.ORCID http://orcid.org/0009-0009-9976-9787
Makoto OnizukaDepartment of Hematology/Oncology, Tokai University School of Medicine, Kanagawa, Japan.ORCID http://orcid.org/0000-0003-3864-0823
Junya KandaDepartment of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID http://orcid.org/0000-0002-6704-3633
Yoshiko AtsutaJapanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan.ORCID http://orcid.org/0000-0003-4404-2870
Hidehiro ItonagaTransfusion and Cell Therapy Unit, Nagasaki University Hospital, Nagasaki, Japan.ORCID http://orcid.org/0000-0003-1438-3623

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42618732

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.